跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 340 条关于
“katG”
全部
340
临床试验
273
药物
51
机构
2
资讯
14
去年
Bedaquiline's Effectiveness Against Drug-Resistant TB Linked to Enzyme Deficiencies
去年
Breakthrough Tuberculosis Drug Targets and Novel Therapeutic Strategies Show Promise Against Drug-Resistant Strains
去年
Closed Loop Medicine Appoints Kate Woolland as CEO to Drive Precision Dosing Commercialization
去年
Olema's KAT6 Inhibitor OP-3136 Shows Promising Anti-Tumor Activity Across Multiple Cancer Types
去年
CorestemChemon Partners with ATG Lifetech to Advance Organoid-Based Preclinical Testing
29天前
EverGlade Adds Former ARPA-H Scientific Advisor Kate Teffer to Expand Federal Health Research Capabilities
去年
Tailored EHR Alerts Fail to Improve AKI Management in Hospitalized Patients: KAT-AKI Trial
去年
Olema Oncology's KAT6 Inhibitor OP-3136 Receives FDA IND Clearance, Phase 1 Trial Planned for 2025
9个月前
IDEAYA Biosciences Submits IND for First-in-Class KAT6/7 Dual Inhibitor IDE574 Targeting Breast and Lung Cancers
去年
Pfizer Advances Australian-Discovered KAT6 Inhibitor PF-07248144 to Phase 3 Trial for HR+/HER2- Metastatic Breast Cancer
第 1 页,共 2 页
上一页
下一页